Xijing Hospital Of Digestive Diseases
Clinical trials sponsored by Xijing Hospital Of Digestive Diseases, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Gut feeling: can a probiotic lift mood in stomach disorder? Results expected Oct 2026 (estimated)
- Gut feeling: probiotic shows promise for mood in stomach disorder Results expected Oct 2026 (estimated)
- Can a common supplement reverse stomach cancer risk? Results expected Dec 2026 (estimated)
- Can 3D vision spot hidden polyps better than standard colonoscopy? Results expected Dec 2026 (estimated)
-
Can a common cholesterol drug help manage a rare liver disease?
Disease control OngoingThis trial is testing the long-term safety of fenofibrate, a drug usually used for high cholesterol, in people with primary biliary cholangitis (PBC), a rare liver disease. The study involves 15 adults who have already completed a previous fenofibrate trial for PBC. Researchers a…
Early phase 1 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Oxygen therapy could tame severe colitis Flare-Ups
Disease control By invitation onlyThis study tests whether adding hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) to standard steroid drugs helps people with severe ulcerative colitis get better faster. About 44 adults with acute severe colitis will be randomly assigned to receive eithe…
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC